A randomized controlled trial of Ninjin yoeito for lung cancer
- Conditions
- lung cancer
- Registration Number
- JPRN-jRCTs051200009
- Lead Sponsor
- Tanaka Yugo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 140
1. Patients over 20 years old with performance status of 0-1 who were diagnosed or suspected with primary lung cancer.
2. Patients undergoing uni-lobectomy with group-2 lymphadenectomy.
3. Patients who consented to the study in writing.
4. Patients scheduled to undergo thoracoscopic surgery including robot-assisted surgery.
1. Patients who have history of allergies in NINJIN-YOUEI-TO in the past.
2. Patients who were treated with Kampo formulation for this symptom within 2 weeks before the start of this study.
3. Patients who have severe anorexia, nausea and vomiting which are careful administration of this drug.
4. Patients whom the doctor judged unsuitable as the subject.
5. Patients who do not retain liver function and kidney function
-Total Bilirubin <=2.0mg/dL
-Serum creatinine <=2.0mg/dL
6. Patients with conversion to open thoracotomy.
7. Patients with pulmonary resection range of 2 or more lobes.
8. Patients who cannot drink water within 3 days after surgery.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CFS (Cancer Fatigue Scale)
- Secondary Outcome Measures
Name Time Method Breathlessness (VAS), Cancer Dyspnea Scale, MD Anderson Symptom Inventory, Basic Check List (Flail Assessment Tool), Spirometry, Effort Force Capacity, 1 Second Amount, 1 Second Rate, Pulmonary Diffusion Ability, Weight, Blood test